Home/Filings/4/0001104659-24-063558
4//SEC Filing

Xynos Konstantinos 4

Accession 0001104659-24-063558

CIK 0001737953other

Filed

May 19, 8:00 PM ET

Accepted

May 20, 8:00 PM ET

Size

5.6 KB

Accession

0001104659-24-063558

Insider Transaction Report

Form 4
Period: 2024-05-16
Xynos Konstantinos
Chief Medical Officer
Transactions
  • Sale

    Common Stock

    2024-05-16$6.47/sh6,367$41,194133,012 total
Footnotes (2)
  • [F1]Represents shares of the Issuer's common stock (the "Shares") sold to cover tax withholding obligations in connection with the partial vesting of the Reporting Person's Restricted Stock Units ("RSU"). The transaction reported herein was made in accordance with the irrevocable "sell to cover" provision set forth in the award agreements under which the RSUs were granted and does not represent a discretionary sale by the Reporting Person.
  • [F2]The price reported reflects a weighted average price of the Shares. The Shares were sold in multiple transactions at prices ranging from $6.46 to $6.56 per Share. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the Securities Exchange Commission staff, upon request, information regarding the number of Shares sold at each price within the range.

Issuer

Replimune Group, Inc.

CIK 0001737953

Entity typeother

Related Parties

1
  • filerCIK 0001956241

Filing Metadata

Form type
4
Filed
May 19, 8:00 PM ET
Accepted
May 20, 8:00 PM ET
Size
5.6 KB